Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
US-10632135-B2 · Apr 28, 2020 · US
This page is not indexed by search engines while we improve data quality.
Michaud Jean Eric patents
Michaud Jean Eric holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 0 |
| First publication | Nov 26, 2019 |
| Latest publication | Apr 28, 2020 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced inflammatory bowel diseases such as crohn's disease
US-2019374559-A1 · Dec 12, 2019 · US
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
US-10485811-B2 · Nov 26, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
US-10632135-B2 · Apr 28, 2020 · US
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced inflammatory bowel diseases such as crohn's disease
US-2019374559-A1 · Dec 12, 2019 · US
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
US-10485811-B2 · Nov 26, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 3 |
| Cross-Sectional Technologies | 3 |